Vector Development
Dendrimers in gene delivery are focus of review
Published in Gene Therapy Weekly, March 2nd, 2006
According to the review from Scotland, "Dendrimers have unique molecular architectures and properties that make them attractive materials for the development of nanomedicines. Key properties such as defined architecture and a high ratio of multivalent surface moieties to molecular volume also make these nanoscaled materials highly interesting for the development of synthetic (non-viral) vectors for therapeutic nucleic acids."
"Rational development of such vectors requires the link to be made between dendrimer structure and the morphology and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-03-02)
More Articles from Gene Therapy Weekly
- Cancer Genetics
PKCalpha expression is regulated by Elk-1 and MZF-1 in hepatocellular carcinoma - Gene Therapy
BACE1 deletion rescues temporal memory deficits in Alzheimer mouse models - Gene Therapy
Direct targeting of modified tumor cells to Fc gamma RI triggers cytotoxicity - Gene Therapy
Inhibitor of Apoptosis Protein 2 regulates innate immune signaling in Drosophila - Gene Therapy
STAT3 activation is differentially regulated in squamous cell carcinomas - Addiction Medicine
New findings in addiction medicine described - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
